Stockscreener 앱 받기
493.99
1.12%
5.48
전일 마감가:
$488.51
열려 있는:
$491
하루 거래량:
491.59K
Relative Volume:
0.84
시가총액:
$21.27B
수익:
$3.08B
순이익/손실:
$1.24B
주가수익비율:
19.29
EPS:
25.6108
순현금흐름:
$1.07B
1주 성능:
+0.96%
1개월 성능:
+7.03%
6개월 성능:
+72.64%
1년 성능:
+36.61%
1일 변동 폭
$488.75
$496.73
1주일 범위
$474.59
$496.73
52주 변동 폭
$266.98
$496.73
유나이티드 테라퓨틱스 Stock (UTHR) Company Profile
명칭
United Therapeutics Corp
전화
(301) 608-9292
주소
1000 SPRING ST, SILVER SPRING, MD
UTHR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
유나이티드 테라퓨틱스 Stock (UTHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Underweight |
| 2025-09-26 | 개시 | RBC Capital Mkts | Outperform |
| 2025-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-02-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2022-12-06 | 개시 | UBS | Buy |
| 2022-12-05 | 개시 | Goldman | Sell |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2022-09-20 | 재확인 | BofA Securities | Underperform |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-02-11 | 개시 | BTIG Research | Neutral |
| 2021-07-14 | 업그레이드 | Argus | Hold → Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-06-25 | 재확인 | H.C. Wainwright | Neutral |
| 2020-03-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-27 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-01-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 개시 | BofA/Merrill | Underperform |
| 2019-08-01 | 업그레이드 | Jefferies | Underperform → Hold |
| 2019-08-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-09 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2018-08-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 재확인 | Barclays | Underweight |
| 2018-01-18 | 재개 | Credit Suisse | Underperform |
| 2017-12-27 | 재확인 | Wedbush | Outperform |
| 2017-04-27 | 재확인 | Wedbush | Outperform |
| 2017-03-30 | 개시 | UBS | Sell |
| 2017-03-16 | 개시 | Credit Suisse | Underperform |
모두보기
유나이티드 테라퓨틱스 주식(UTHR)의 최신 뉴스
Paul Mahon Sells 11,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
AQR Capital Management LLC Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
United Therapeutics stock hits all-time high at 492.62 USD - Investing.com
Globeflex Capital L P Grows Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Investment Management Corp of Ontario Has $1.57 Million Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 187 Shares of Stock - MarketBeat
Insider Sell: Nilda Mesa Sells Shares of United Therapeutics Cor - GuruFocus
California Public Employees Retirement System Sells 35,211 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) CFO Sells $10,050,600.00 in Stock - MarketBeat
Why a $27 Million Buy Signals New Confidence in Weatherford Stock - The Motley Fool
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term - Yahoo Finance
Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR] - TradingView
Rothblatt, United Therapeutics CEO, sells $3.8m in UTHR stock By Investing.com - Investing.com Canada
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares - MarketBeat
Rothblatt, United Therapeutics CEO, sells $3.8m in UTHR stock - Investing.com
United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing - marketscreener.com
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
Chmn Rothblatt Sells 8,000 ($3.9M) Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics Corporation $UTHR Shares Sold by L2 Asset Management LLC - MarketBeat
Invesco Ltd. Grows Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Acquired by Marshall Wace LLP - MarketBeat
United Therapeutics Corporation $UTHR Position Cut by Schroder Investment Management Group - MarketBeat
Epoch Investment Partners Inc. Has $83.76 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR): Revisiting Valuation After Q3 2025 Growth, Strong 2027 Guidance and Rising Institutional Interest - simplywall.st
UTHR SEC FilingsUnited Therapeutics Corp. 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
State Board of Administration of Florida Retirement System Has $12.22 Million Position in United Therapeutics Corporation $UTHR - MarketBeat
Russell Investments Group Ltd. Lowers Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Executives Sell Shares Under 10b5-1 Trading Plans - TradingView
Korea Investment CORP Sells 18,300 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Pres Benkowitz Files To Sell 112,500 Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics Corporation $UTHR Shares Acquired by Hsbc Holdings PLC - MarketBeat
Virtus Investment Advisers LLC Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat
XTX Topco Ltd Has $1.39 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
1,280 Shares in United Therapeutics Corporation $UTHR Purchased by Inceptionr LLC - MarketBeat
Charles Schwab Investment Management Inc. Decreases Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Is United Therapeutics Still a Hidden Gem After 34.9% Share Price Surge in 2025? - simplywall.st
Vinva Investment Management Ltd Raises Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
What is the fair value of United Therapeutics Corporation stock nowEarnings Overview Report & High Yield Equity Trading Tips - moha.gov.vn
Insider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells 11,000 Shares of Stock - MarketBeat
United Therapeutics Corporation $UTHR Shares Bought by Legal & General Group Plc - MarketBeat
United Therapeutics Executives Sell Shares Worth Over $15 Million - TradingView
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
Journey Strategic Wealth LLC Takes Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Stock Unloaded Rep. Lisa C. McClain - MarketBeat
Chmn Rothblatt Sells 8,000 ($3.8M) Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics stock hits all-time high at 485.43 USD - Investing.com
Vanguard Group Inc. Sells 8,287 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Prudential PLC Raises Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Has $12.56 Million Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
유나이티드 테라퓨틱스 (UTHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
유나이티드 테라퓨틱스 주식 (UTHR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Dec 11 '25 |
Option Exercise |
146.03 |
11,000 |
1,606,330 |
47,781 |
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Dec 11 '25 |
Sale |
484.67 |
11,000 |
5,331,316 |
36,781 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Dec 11 '25 |
Option Exercise |
120.26 |
4,000 |
481,040 |
4,130 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Dec 12 '25 |
Option Exercise |
120.26 |
4,000 |
481,040 |
4,130 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Dec 12 '25 |
Sale |
490.70 |
4,000 |
1,962,783 |
130 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Dec 11 '25 |
Sale |
483.97 |
4,000 |
1,935,879 |
130 |
1.26%
0.52%
자본화:
|
볼륨(24시간):